Abhishek Vijukumar

Abhishek Vijukumar

Auto-generated profile, based on publicly available information

Abhishek Vijukumar

ISF College of Pharmacy, Moga, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
AVAbhishek Vijukumar
Abhishek Vijukumar
AKAryan Kumar
Aryan Kumar
HKHardik Kumar
Hardik Kumar

14 March 2025
Verified
Book Chapter
Closed access
SDSujata P. Dudhe
Sujata P. Dudhe
PDPrashik B. Dudhe
Prashik B. Dudhe
SMSonali M. Mundhe
Sonali M. Mundhe
RRRojin G Raj
Rojin G Raj
AVAbhishek Vijukumar
Abhishek Vijukumar
Perli Kranti KumarPerli Kranti Kumar
Perli Kranti Kumar
This chapter explores the transformation of education through technology, focusing on the shift from traditional to digital methods. Key innovations like artificial intelligence, virtual and augmented reality, learning management systems, and cloud computing have revolutionized personalized learning and accessibility. Historical developments, from early educational tools to MOOCs, highlight their role in expanding global reach. The chapter addresses challenges such as the digital divide, quality assurance, and teacher re-skilling, emphasizing the importance of policies in fostering inclusive education. Future directions include hybrid models, immersive learning experiences, and AI-driven systems, blending traditional and digital approaches to create dynamic, student-centered environments.

11 October 2025 in Next Research
Verified
Journal Article
Closed access
KAKamaljeet
Kamaljeet
INIshrat Nazir
Ishrat Nazir
AVAbhishek Vijukumar
Abhishek Vijukumar
SKSourabh Kosey
Sourabh Kosey
AKAmandeep Kaur
Amandeep Kaur

31 December 2025
Verified
Journal Article
Closed access
AVAbhishek Vijukumar
Abhishek Vijukumar
HSHarkomal Singh
Harkomal Singh
TKTarun Kalra
Tarun Kalra
BSBintoo Sharma
Bintoo Sharma
Alkaptonuria is believed to be a rare autosomal recessive disease caused by an imbalance in homogentisate 1,2 dioxygenase (HGD). HGA builds up in the body when the HGD enzyme isn't working correctly, despite the kidneys' ability to frequently remove it. The diagnosis of AKU may not occur until the ochronotic arthropathy manifests, which usually happens in adulthood. There is a paucity of information on the condition's early stages and infancy. The development of a dark color formation in urine, dried urine spot (DUS), immunofluorescence, Thioflavin T (Th-T) staining, Congo Red (CR) staining, and transmission electron microscopy (TEM) may all be used to detect this. Ascorbic acid, phenylalanine and tyrosine diet restrictions, and the only medication approved by the European Medicine Agency as the first disease-modifying treatment for individuals with AKU is nitisinone, which has demonstrated promise as an additional treatment for alkaptonuria.

25 April 2026 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
KAKamaljeet
Kamaljeet
INIshrat Nazir
Ishrat Nazir
AVAbhishek Vijukumar
Abhishek Vijukumar
YMYavnika Minhas
Yavnika Minhas
SKSourabh Kosey
Sourabh Kosey
MHMohd Haneef
Mohd Haneef